Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium

BACKGROUND: Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the Netherlands and Belgium through a named patient pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreeftmeijer-Vegter, Annemarie R, van Genderen, Perry J, Visser, Leo G, Bierman, Wouter FW, Clerinx, Jan, van Veldhuizen, Cees KW, de Vries, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364861/
https://www.ncbi.nlm.nih.gov/pubmed/22462806
http://dx.doi.org/10.1186/1475-2875-11-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364861/
https://www.ncbi.nlm.nih.gov/pubmed/22462806
http://dx.doi.org/10.1186/1475-2875-11-102

Ejemplares similares